Search Results 681-690 of 23650 for B cell lymphomas

  1. Linda M. McAllister, M.D., Ph.D. - Mayo Clinic Faculty Profiles

    ... B-cell diffuse large B-cell lymphoma (ABC-DLBCL) and multiple other subtypes of lymphoma and leukemia. ... This activity promotes tumor cell proliferation through ...

  2. Saad J. Kenderian, M.B., Ch.B. - Mayo Clinic Faculty Profiles

    Using the immune system to treat cancer (immunotherapy) has emerged as a potent and potentially curative modality. The recent success of engineered T cell ...

  3. Medical Research & Education - Mayo Clinic News Network

    ... B-Cell Lymphoma featured image. Cancer. Everolimus R-CHOP Combination Safe for Treating Diffuse Large B-Cell Lymphoma. Joe Dangor. June 29, 2016. First ...

  4. Hematology - Clinical trials

    AZD0486 As Monotherapy In Participants With Relapsed/Refractory (R/R) B-cell NHL. Rochester, Minn. This is a Phase 2 global, multi-center, open-label study ...

  5. Paul J. Hampel, M.D. - Doctors and Medical Staff - Mayo Clinic

    ... lymphoma, hairy cell leukemia, and T-cell prolymphocytic leukemia. Dr ... B-cell lymphoma · Burkitt lymphoma · Chronic lymphocytic leukemia · Follicular ...

  6. Mazie Tsang, M.D. - Doctors and Medical Staff - Mayo Clinic

    Mazie Tsang, M.D., MAS, MS, is a hematologist who specializes in the care of lymphoma and chronic lymphocytic leukemia. ... B-cell lymphoma · Chronic lymphocytic ...

  7. Medical Research & Education - Mayo Clinic News Network

    ... B-Cell Lymphoma featured image. Cancer. Everolimus R-CHOP Combination Safe for Treating Diffuse Large B-Cell Lymphoma. Joe Dangor. June 29, 2016. First ...

  8. Central nervous system (CNS) lymphoma - Diagnosis and treatment - Mayo Clinic

    Diffuse large B-cell lymphoma of the central nervous system. In: Hematology: Basic Principles and Practice. 8th ed. Elsevier; 2023. https://www.clinicalkey ...

  9. A Study Evaluating The Safety, Efficacy, And Pharmacokinetics Of Mosunetuzumab And A Combined Regimen Of Mosunetuzumab And Venetoclax In Participants With Relapsed Or Refractory Chronic Lymphocytic Leukemia - Mayo Clinic

    ... B-cell lymphoma 2 (BCL2) inhibitor. Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous ...

  10. Stephen M. Ansell, M.D., Ph.D. - Doctors and Medical Staff - Mayo Clinic

    B-cell lymphoma · Burkitt lymphoma · Follicular lymphoma · Hodgkin lymphoma · Non-Hodgkin lymphoma · Peripheral T-cell lymphoma · Procedures performed.